ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for advanced lung cancer: new drug cocktails under study
Disease control Recruiting nowThis study is for people with advanced or metastatic non-small cell lung cancer. It tests new combinations of cancer drugs to see if they are safe and can shrink tumors. About 152 participants will receive different drug mixes, and researchers will monitor side effects and how we…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 00:59 UTC
-
New combo aims to outperform standard immunotherapy for lung cancer
Disease control Recruiting nowThis study tests whether a new drug combination (SHR-8068 plus adebrelimab and chemotherapy) works better than the current standard (tislelizumab plus chemotherapy) for people with advanced or metastatic non-small cell lung cancer who have not had prior treatment. About 460 adult…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for lung cancer: drug cocktails tested in major trial
Disease control Recruiting nowThis study tests new combinations of drugs in people with non-small-cell lung cancer. It includes three groups: those with newly diagnosed advanced cancer, those whose cancer has returned after treatment, and those with early-stage cancer that can be surgically removed. The goal …
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for advanced lung cancer: drug combo trial opens
Disease control Recruiting nowThis study tests a new drug (SHR-A2102) combined with another drug (adebrelimab) for people with advanced or metastatic non-small cell lung cancer. The goal is to find the safest and most effective dose and see if the combination shrinks tumors. About 248 adults aged 18-70 with m…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC